ABIVAX (EPA:ABVX) | Finanzwire

Basculer en Français

10816	Companies
234387	Keywords
163195	Articles
125354	Press releases

Home
Companies
ABIVAX

PRESS RELEASE

published on 06/29/2026 at 22:05, 1 month 10 days ago

Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory UC Patients and Strengthening the Phase 3 Maintenance Safety Database
Abivax reports positive ABTECT Maintenance Part 2 results for obefazimod in refractory UC patients, demonstrating meaningful clinical benefit and strengthening safety database

Abivax Obefazimod Clinical Benefit UC Patients Safety Database
BRIEF

published on 06/17/2026 at 18:05, 1 month 22 days ago

ABIVAX: Distribution of Shares and Voting Rights as of May 31, 2026

Voting Rights Shares Euronext AMF Abivax
BRIEF

published on 06/02/2026 at 10:16, 2 months 8 days ago

Bank of America Corporation exceeds 5% of ABIVAX's capital

Actions Abivax Financial Market Crossing Thresholds Bank Of America
BRIEF

published on 06/01/2026 at 22:10, 2 months 8 days ago

Promising results of obefazimod in the treatment of ulcerative colitis

Abivax Obefazimod Ulcerative Colitis Clinical Trial FDA Authorization
BRIEF

published on 06/01/2026 at 22:10, 2 months 8 days ago

Abivax Announces Phase 3 Trial Results for Ulcerative Colitis Treatment

Abivax Obefazimod Ulcerative Colitis Clinical Trial Phase 3 Results
PRESS RELEASE

published on 06/01/2026 at 22:05, 2 months 8 days ago

Abivax Announces Landmark Phase 3 ABTECT Maintenance Trial Results Evaluating Obefazimod in Moderately to Severely Active Ulcerative Colitis
Abivax announces positive Phase 3 ABTECT maintenance trial results for obefazimod in ulcerative colitis, demonstrating significant efficacy and safety profile. Plans NDA submission to FDA in late 2026

FDA Abivax Obefazimod Ulcerative Colitis Phase 3
BRIEF

published on 05/29/2026 at 18:05, 2 months 11 days ago

ABIVAX: Update on capital and voting rights

Share Capital Voting Rights Actions AMF Abivax
BRIEF

published on 05/29/2026 at 18:05, 2 months 11 days ago

ABIVAX: Share Capital and Voting Rights as of April 30, 2026

Euronext Paris Share Capital Voting Rights AMF Abivax
BRIEF

published on 05/22/2026 at 22:10, 2 months 18 days ago

Abivax Reports Q1 2026 Financials and Key Developments in Obefazimod Trials

Financial Results Abivax Obefazimod Ulcerative Colitis Clinical Trials
BRIEF

published on 05/22/2026 at 22:10, 2 months 18 days ago

Abivax unveils its Q1 2026 results and progress on Study 108

Financial Results Treasury Obefazimod RCH Study 108

Accesswire

Published on 08/10/2026 at 15:30, 11 minutes ago

Silver Spruce Resources, Inc. Announces New Chief Financial Officer
Published on 08/10/2026 at 15:25, 16 minutes ago

Gemdale Gold Intersects 5.19m at 14.01 g/t Au within 110m at 1.18 g/t Au at the Pontio Gold Project, Finland
Published on 08/10/2026 at 14:30, 1 hour 11 minutes ago

NanoViricides Has Received Regulatory Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo To Fight the Current Largest Ever and Expanding Ebola Outbreak
Published on 08/10/2026 at 13:30, 2 hours 11 minutes ago

Sterling Expands High-Grade Copper Mineralization East at MEPS Intersecting 203 Metres at 0.51% CuEq: Includes 16.25 Metres at 2.31% CuEq and 9.50 Metres at 2.34% CuEq within 445 Metres at 0.40% CuEq
Published on 08/10/2026 at 13:00, 2 hours 41 minutes ago

Alaska Energy Metals Announces Drilling Program for the Mcbride Prospect, Angliers-Belleterre Project, Quebec, Canada

View all ACCESSWIRE

EQS Group

Published on 08/10/2026 at 15:38, 2 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 08/10/2026 at 15:37, 4 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Mitie Group plc
Published on 08/10/2026 at 15:35, 5 minutes ago

Form 8.3 - The Vanguard Group, Inc.: JTC plc
Published on 08/10/2026 at 15:25, 15 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Intertek Group plc
Published on 08/10/2026 at 15:23, 17 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Gamma Communications plc

Les Echos

Published on 08/10/2026 at 11:53, 3 hours 47 minutes ago

GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
Published on 08/10/2026 at 11:36, 4 hours 4 minutes ago

GUILLEMOT CORPORATION| Weekly report share buyback from August 3 to August 7 2026
Published on 08/10/2026 at 09:22, 6 hours 18 minutes ago

Number of shares and voting rights - July 2026 (In French only)
Published on 08/10/2026 at 07:00, 8 hours 41 minutes ago

BIOPHYTIS ANNOUNCES APPROVAL OF THE OBA CLINICAL TRIAL IN BRAZIL AND SHARES ITS OUTLOOK FOR BIO101 IN OBESITY
Published on 08/07/2026 at 18:54, 2 days 20 hours ago

Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026

View all LES ECHOS COMFI WIRE